Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)

OBJECTIVES: Although not licensed for acute bipolar depression, lamotrigine has evidence for efficacy in trials and its use is recommended in guidelines. So far there had been no prospective health economic evaluation of its use. METHODS: Cost‐utility analysis of the CEQUEL trial comparing quetiapin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bipolar Disord
Autori principali: Simon, Judit, Geddes, John R., Gardiner, Alexandra, Rendell, Jennifer, Goodwin, Guy M., Mayer, Susanne
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491973/
https://ncbi.nlm.nih.gov/pubmed/30375699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bdi.12713
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi